← Back to Clinical Trials
Recruiting NCT06715852

NCT06715852 Moving on! A Tailored Treatment in a Primary Care Setting for Individuals With Anxiety Disorders?

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06715852
Status Recruiting
Phase
Sponsor Vastra Gotaland Region
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 450 participants
Start Date 2025-03-17
Primary Completion 2027-12-31

Trial Parameters

Condition Anxiety
Sponsor Vastra Gotaland Region
Study Type INTERVENTIONAL
Phase N/A
Enrollment 450
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2025-03-17
Completion 2027-12-31
Interventions
PHYSBI: a 12-week physical exercise programModified eHealth Lift: a digital, evidence based lifestyle-intervention for health promotion.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical study is to investigate the effects of two different interventions in patients with anxiety disorder and who seeks help at primary care centers. The participants will choose between two interventions: 1. A 12-week physical exercise program with three training sessions per week, or 2. A modified version of eHealth Lift, a digital development of the Health Lift, an evidence based lifestyle-intervention for health promotion and prevention in primary health care. The participant will fill in self-assessment scales and questionnaires and also have BMI and blood pressure measured at the start of the study, at 12-weeks after the study start and after 1 year. The main question the investigators aim to answer is if the interventions are better than treatment as usual for this group of patients regarding: * symptoms of anxiety and depression * pain * sleep * alcohol habits * fatigue * general health * work ability/sick leave * physical activity * perceived quality of life * BMI and blood pressure * number of health care contacts * psychopharmaceuticals and analgesics prescribed * health literacy

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of anxiety disorder (panic syndrome, 41.0; generalized anxiety, F41.1; mixed anxiety- and depression, F41.2 and F41.3; anxiety not otherwise specified, F41.9). * Seeking care at primary care centers within the Region Västra Götaland. * With or without ongoing treatment with psychoactive medication (antidepressants or anxiolytics). Exclusion Criteria: * Pregnancy * Physical difficulties in performing a physical exercise program * Pathological electrocardiogram * Low BMI (under 17.5) * Ongoing alcohol/substance abuse * Ongoing exhaustion disorder or psychotic disorder * Newly discovered (within 6 months) atrial fibrillation * High suicide risk as assessed by the general practitioner * Limited knowledge in the Swedish language.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology